Table 8.

Post-microwave ablation (MWA) therapies received

Post-MWA therapy	Incidence
Systemic chemotherapy
Yes. Number of regimens received:	37 (74%)
1 Regimen	12/37 (32%)
2 Regimens	12/37 (32%)
≥ 3 Regimens	13/37 (35%)
No	13 (26%)
Target therapy (EGFR inhibitors/antibody, anti-VEGF, tyrosine kinase inhibitors)
Yes	29 (58%)
No	21 (42%)
Lung ablation
Yes	19 (38%)
No	31 (62%)
Lung resection
Yes	5 (10%)
No	45 (90%)
Other therapies (radiotherapy, resection or ablation of the other tumor sites, Y-90 RAE, HAIP, immunotherapy)
Yes	28 (56%)
No	22 (44%)
Patients off-treatment after MWA due to no evidence of disease, low volume of disease or due side effects/comorbidities
Yes	5 (10%)
No	45 (90%)

RAE radioembolization, HAIP hepatic artery infusion pump